Neurological disorders and glaucoma - An overview;Neurologische Erkrankungen und Glaukom - ein Überblick

Klinische Monatsblatter fur Augenheilkunde

Volumn 231, Issue 2, 2014, Pages 130-135

  Gobel K ^a   Erb, C ^b  

^a Schlosspark Klinik   (Germany)

^b Augenklinik Am Wittenbergplatz   (Germany)

Author keywords

Alzheimer's disease; glaucoma; multiple sclerosis; neurodegenerative disorders; neuroophthalmology; Parkinson's disease

Indexed keywords

EVIDENCE-BASED MEDICINE; GLAUCOMA; HUMANS; MODELS, BIOLOGICAL; NEURODEGENERATIVE DISEASES; OPTIC NERVE DISEASES;

EID: 84894237805     PISSN: 00232165     EISSN: 14393999     Source Type: Journal    
DOI: 10.1055/s-0033-1360316     Document Type: Review

References (64)

1. Harwerth R. S., Carter-Dawson L., Shen F. et al. Ganglion cell losses underlying visual field defects from experimental glaucoma. Invest Ophthalmol Vis Sci: 1999; 40 2242 2250 (Pubitemid 29418378)
2. Zilles K., Rehkämper G. Funktionelle Neuroanatomie - Lehrbuch und Atlas. Berlin, Heidelberg, New York Springer: 1993
3. Schiebler T. H., Schmidt W. Anatomie. 5. Aufl. Berlin, Heidelberg Springer: 1991
4. Jindal V. Glaucoma: an extension of various chronic neurodegenerative disorders. Mol Neurobiol: 2013; 48 186 189
5. Jarvic L., Greenson H. About a peculiar disease of the cerebral cortex. By Alois Alzheimer. Alzheimer Dis Assoc Disord: 1987; 1 3 8
6. Fratiglioni L., Paillard-Borg S., Winblad B. An active and socially integrated lifestyle in late night protect against dementia. Lancet Neurol: 2004; 3 343 353 (Pubitemid 38648855)
7. Ballard C., Gauthier S., Corbett A. et al. Alzheimer's disease. Lancet: 2011; 377 1019 1031
8. Kukull W. A., Higdon R., Bowen J. D. et al. Dementia and Alzheimer disease incidence: a prospective cohort study. Arch Neurol: 2002; 59 1737 1746 (Pubitemid 35340484)
9. Mumenthaler M., Mattle H. Neurologie. 10. Aufl. Stuttgart Thieme: 1997
10. Alves L., Correia A. SA, Miguel R. et al. Alzheimer's disease: a clinical practice-oriented review. Front Neurol: 2012; 3 1 20
11. Reitz C. Alzheimer's disease and the amyloid cascade hypothesis: a critical review. Int J Alzheimers Dis: 2012; 10.1155/2012/369808
12. Cai Z., Zhao B., Ratka A. Oxidative stress and β-amyloid protein in Alzheimer's disease. Neuromolecular Med: 2011; 13 223 250
13. Nelson P. T., Head E., Schmitt F. A. et al. Alzheimer's disease is not brain-aging: neuropathological, genetic, and epidemiological human studies. Acta Neuropathol: 2011; 121 571 587
14. Reddy P. H. Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimers disease. Brain Res: 2011; 1415 136 148
15. Wostyn P., Audenaert K., de Deyn P. P. Alzheimers disease: cerebral glaucoma? Med Hypotheses: 2010; 74 973 977
16. Bayer A. U., Ferrari F., Erb C. High occurence rate of glaucoma among patients with Alzheimers disease. Eur Neurol: 2002; 47 165 168 (Pubitemid 34253039)
17. Wostyn P., Audenaert K., de Deyn P. P. Alzheimers disease and glaucoma: is there a causal relationship? Br J Ophthalmol: 2009; 93 1557 1559
18. Phillips E. C. Alzheimers disease and glaucoma. Br J Ophthalmol: 2011; 95 152 author reply 152 - 153
19. Jackson G. R., Owsley C. Visual dysfunction, neurodegenerative diseases, and aging. Neurol Clin: 2003; 21 709 728 (Pubitemid 36754063)
20. Bayer A. U., Keller O. N., Ferrari F. et al. Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimers disease and Parkinsons disease. Am J Ophthalmol: 2002; 133 135 137 (Pubitemid 34076513)
21. Tamura H., Kawakami H., Kanamoto T. et al. High frequency of open-angle glaucoma in Japanese patients with Alzheimers disease. J Neurol Sci: 2006; 246 79 83 (Pubitemid 43815345)
22. Kesler A., Vakhapova V., Korczyn A. D. et al. Retinal thickness in patients with mild cognitive impairment and Alzheimers disease. Clin Neurol Neurosurg: 2011; 113 523 526
23. Bach-Holm D., Kessing S. V., Mogensen U. et al. Normal tension glaucoma and Alzheimer disease: comorbidity? Acta Ophthalmol: 2012; 90 683 685
24. Kessing L. V., Lopez A. G., Andersen P. K. et al. No increased risk of developing Alzheimer disease in patients with glaucoma. J Glaucoma: 2007; 16 47 51 (Pubitemid 46114773)
25. Wang N., Jonas J. B. Low cerebrospinal fluid pressure in the pathogenesis of primary open-angle glaucoma: epiphenomenon or causal relationship? The Beijing Intracranial and Intraocular Pressure (iCOP) study. J Glaucoma: 2013; 22 05 S11 S12
26. Wostyn P., Audenaert K., de Deyn P. P. More advanced Alzheimers disease may be associated with a decrease in cerebrospinal fluid pressure. Cerebrospinal Fluid Res: 2009; 6 14
27. Inoue T., Kawaji T., Tanihara H. Elevated levels of multiple biomarkers of Alzheimers disease in the aqueous humor of eyes with open-angle glaucoma. Invest Ophthalmol Vis Sci: 2013; 54 5353 5358
28. Vickers J. C., Craig J. E., Stankovich J. et al. The apolipoprotein epsilon4 gene is associated with elevated risk of normal tension glaucoma. Mol Vis: 2002; 8 389 393 (Pubitemid 36153629)
29. Nowacka B., Lubinski W., Karczewicz D. Ophthalmological and electrophysiological features of Parkinsons disease. Klin Oczna: 2010; 112 247 252
30. Janciauskiene S., Westin K., Grip O. et al. Detection of Alzheimers peptides and chemokines in the aqueous humor. Eur J Ophthalmol: 2011; 21 104 111
31. Osborne N. N. Recent clinical findings with memantine should not mean that the idea of neuroprotection in glaucoma is abandoned. Acta Ophthalmol: 2009; 87 450 454
32. Schröder A., Erb C. Einsatz von Memantine bei Glaucoma fere absolutum. Eine Kasuistik. Klin Monatsbl Augenheilkd: 2002; 219 533 536 (Pubitemid 35024110)
33. Göbel K., Erb C. Klinische Aspekte der neuroprotektiven Therapie mit Memantine in der Behandlung von Glaukomen. In: Erb C. Hrsg. Search on Glaucoma. Amsterdam Excerpta Medica: 2010; 95 101
34. Parkinson J. An essay on the shaking palsy. J Neuropsychiatry Clin Neurosci: 2002; 14 223 236
35. Bodis-Wollner I., Marx M. S., Mitra S. et al. Visual dysfunction in Parkinsons disease. Loss in spatiotemporal contrast sensitivity. Brain: 1987; 110 1675 1698
36. Rodnitzky R. L. Visual dysfunction in Parkinsons disease. Clin Neurosci: 1998; 5 102 106
37. Silva M. S., Faria P., Regateiro F. S. et al. Independent patterns of damage within magno-, parvo- and koniocellular pathways in Parkinsons disease. Brain: 2005; 128 2260 2271 (Pubitemid 41407966)
38. Frederick J. M., Rayborn M. E., Laties A. M. Dopaminergic neurons in the human retina. J Comp Neurol: 1982; 210 65 79 (Pubitemid 12021000)
39. Harnois C., Di Paolo T. Decreased dopamine in the retinas of patients with Parkinsons disease. Invest Ophthalmol Vis Sci: 1990; 31 2473 2475
40. Djamgoz M. B., Hankins M. W., Hirano J. Neurobiology of retinal dopamine in relation to degenerative states of the tissue. Vision Res: 1997; 37 3509 3529 (Pubitemid 27491631)
41. Ikeda H., Head G. M., Ellis C. J. Electrophysiological signs of retinal dopamine deficiency in recently diagnosed Parkinsons disease and a follow up study. Vision Res: 1994; 34 2629 2638 (Pubitemid 24256856)
42. Sartucci F., Orlandi G., Lucetti C. Changes in pattern electroretinograms to equiluminant red-green and blue-yellow gratings in patients with early Parkinsons disease. J Clin Neurophysiol: 2003; 20 375 381 (Pubitemid 38031212)
43. Tagliati M., Bodis-Wollner I., Yahr M. D. The pattern electroretinogram in Parkinsons disease reveals lack of retinal spatial tuning. Electroencephalogr Clin Neurophysiol: 1996; 100 1 11
44. Blumenthal E. Z., Williams J. M., Weinreb R. N. et al. Reproducibility of nerve fiber layer thickness measurements by use of optical coherence tomography. Ophthalmology: 2000; 107 2278 2282
45. Garcia T., Tourbah A., Setrouk E. et al. Optical coherence tomography in neuro-ophthalmology. J Fr Ophthalmol: 2012; 35 454 466
46. Pasol J. Neuro-ophthalmic disease and optical coherence tomography: glaucoma look-alikes. Curr Opin Ophthalmol: 2011; 22 124 132
47. Lalezary M., Medeiros F. A., Weinreb R. N. et al. Baseline optical coherence tomography predicts the development of glaucomatous change in glaucoma suspects. Am J Ophthalmol: 2006; 142 576 582
48. Yenice O., Onal S., Midi I. et al. Visual field analysis in patients with Parkinsons disease. Parkinsonism Relat Disord: 2008; 14 193 198 (Pubitemid 351458421)
49. Tsironi E. E., Dastiridou A., Katsanos A. et al. Perimetric and retinal nerve fiber layer findings in patients with Parkinsons disease. BMC Ophthalmol: 2012; 12 54
50. Marques I. B., Matias F., Silva E. D. et al. Risk of multiple sclerosis after optic neuritis in patients with normal baseline brain MRI. J Clin Neurosci: 2013; 10.1016/j.jocn.2013.06.013
51. Optic Neuritis Study Group Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. Arch Neurol: 2008; 65 727 732
52. Chan J. W. Optic neuritis in multiple sclerosis. Ocul Immunol Inflamm: 2002; 10 161 186 (Pubitemid 36754187)
53. Kallenbach K., Frederiksen J. Optical coherence tomography in optic neuritis and multiple sclerosis: a review. Eur J Neurol: 2007; 14 841 849 (Pubitemid 47106757)
54. Fisher J. B., Jacobs D. A., Markowitz C. E. et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology: 2006; 113 324 332 (Pubitemid 43170783)
55. Merle H., Olindo S., Donnio A. et al. Retinal nerve fiber layer thickness and spatial and temporal contrast sensitivity in multiple sclerosis. Eur J Ophthalmol: 2010; 20 158 166
56. Ruseckaite R., Maddess T., Danta G. et al. Frequency doubling illusion VEPs and automated perimetry in multiple sclerosis. Doc Ophthalmol: 2006; 113 29 41 (Pubitemid 44390742)
57. Göbel K., Schmidt M., Erb C. et al. Berlin-Brandenburgische Augenärztliche Gesellschaft Hat die Multiple Sklerose ohne Optikusneuritis Einfluss auf perimetrische Untersuchungen? Klin Monatsbl Augenheilkd: 2013; 230 02 S3
58. Keltner J. L., Johnson C. A. Short-wavelength automated perimetry in neuro-ophthalmologic disorders. Arch Ophthalmol: 1995; 113 475 481
59. Kitsos G., Detorakis E. T., Papakonstantinou S. et al. Perimetric and peri-papillary nerve fibre layer thickness findings in multiple sclerosis. Eur J Ophthalmol: 2010; 18 719 725
60. Bock M., Brandt A. U., Dörr J. et al. Patterns of retinal nerve fibre layer loss in multiple sclerosis patients with or without optic neuritis and glaucoma patients. Clin Neurol Neurosurg: 2010; 112 647 652
61. Joachim S. C., Reichelt J., Berneiser S. et al. Sera of glaucoma patients show autoantibodies against myelin basic protein and complex autoantibody profiles against human optic nerve antigens. Graefes Arch Clin Exp Ophthalmol: 2008; 246 573 580
62. Findling O., Durot I., Weck A. et al. Anti-myelin antibodies as predictors of disability after clinically isolated syndrome. Int J Neurosci: 2013; 10.3109/00207454.2013.869221 [Epub ahead of print] 10.3109/00207454.2013. 869221
63. Erb C., Batra A., Lietz A. et al. Psychological characteristics of patients with normal-tension glaucoma. Graefes Arch Clin Exp Ophthalmol: 1999; 237 753 757 (Pubitemid 29405724)
64. McKinnon S. J. The cell and molecular biology of glaucoma: common neurodegenerative pathways and relevance to glaucoma. Invest Ophthalmol Vis Sci: 2012; 53 2485 2487